eMERGE is a national network organized and funded by the National Human Genome Research Institute (NHGRI) that combines DNA biorepositories with electronic medical record (EMR) systems for large scale, high-throughput genetic research in support of implementing genomic medicine.
Many factors contribute to risk of a disease. Some of these factors are internal, like genetics, and others are external, like where someone lives. Over the last several years researchers have discovered that in addition to one gene being associated with a given disease (monogenic factors), many genes across your genome can contribute to the development of a disease (polygenic factors). To learn more about elements that contribute to risk a disease, click here.
Latest News
Hybrid Workshop: Sustaining Community Engagement in Genomics Research
May 5, 2024 7:01 PM
MAGen NOFOs published
May 5, 2024 3:13 PM
NIH Funding Announcement: Research Opportunity Announcement (ROA) “Integrating Clinical Research into Primary Care Settings through Network Research Hubs – A Pilot (OT2)”
May 5, 2024 3:12 PM
Webinar: NIH Grants Process: Walk-Through for Beginners
May 5, 2024 7:47 PM
NOSI: Supporting the Exploration of Cloud in NIH-supported Research
April 4, 2024 4:31 PM
NOITPs are published
April 4, 2024 4:30 PM
Recent Publications
Moore A, Ritchie MD. Cross-phenotype associations between Alzheimer's Disease and its comorbidities may provide clues to progression. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science. 2024;2024:623-631.
Bagheri M, Bombin A, Shi M, Murthy VL, Ferguson JF. Genotype-based "virtual" metabolomics in a clinical biobank identifies novel metabolite-disease associations. Frontiers in genetics. 2024;15:1392622.
Belloy ME, Guen YL, Stewart I, Herz J, Greicius MD, et al. The Role of X Chromosome in Alzheimer's Disease Genetics. medRxiv : the preprint server for health sciences. 2024 Apr 23;.